Australia's Leading Ophthalmic Magazine Since 1975

     Free Sign Up     

Australia's Leading Ophthalmic Magazine Since 1975

     Free Sign Up     
News

Centre for Eye Research Australia reveals new director

26/09/2018By Matthew Woodley
The youngest full Professor in the history of Cambridge University’s Clinical School has been appointed as managing director of the Centre for Eye Research Australia (CERA).

Professor Keith Martin, who also co-founded Cambridge spinoff gene therapy company Quethera – sold for around £85 million (AU$153 m) in August – will take up the role in February.

“We were heartened by the fantastic response and the high calibre of candidates who applied for the role, but Keith was the outstanding candidate,” CERA chair Ms Olivia Hilton said.

“He has a strong commitment to eye research, experience, passion and energy to lead CERA into the future.”


“My new role in Melbourne will provide a unique opportunity to lead the next stage of the development of CERA as an internationally outstanding research institute.”
Keith Martin, CERA

Martin specialises in advanced and complex glaucoma in adults and children, particularly uveitic glaucoma. He will also take up the position of Ringland Anderson Chair at the University of Melbourne, and says he is delighted to accept the opportunity.

“Under the dynamic leadership of Jonathan Crowston, and in partnership with the University of Melbourne and The Royal Victorian Eye and Ear Hospital, CERA has consolidated its reputation as one of the leading eye research institutes in the world,” Martin said.

“Moving from the University of Cambridge has not been an easy decision, but I believe my new role in Melbourne will provide a unique opportunity to lead the next stage of the development of CERA as an internationally outstanding research institute that helps translationally-focused clinicians and scientists to change lives.”

Martin’s groundbreaking research proved that gene therapy and stem cell therapy could reduce optic nerve damage in experimental models of glaucoma. His other current main research interest is in the potential for regeneration and repair of nerve damage in the eye and brain.

largeleaderboard_0618
advertisement


skyscraper_article
advertisement
Editor's Suggestion
Hot Stories

OR
 

Subscribe for Insight in your Inbox

Get Insight with the latest in industry news, trends, new products, services and equipment!